Differentiation of Postoperative Tumor Recurrence and Pseudoprogression in Gliomas: A Comparative Study of Six Diffusion Models
- PMID: 40774877
- DOI: 10.1016/j.acra.2025.07.036
Differentiation of Postoperative Tumor Recurrence and Pseudoprogression in Gliomas: A Comparative Study of Six Diffusion Models
Abstract
Rationale and objectives: The purpose of this study is to investigate whether six diffusion models derived from multi-b-value diffusion-weighted imaging can enhance the differentiation between pseudoprogression (PsP) and postoperative tumor recurrence (TR) in glioma patients, with the aim of providing clinical insights.
Materials and methods: A retrospective study was conducted on 82 patients with WHO grade 2-4 gliomas who underwent surgery at our hospital, with MRI sequences including T1WI, T2WI, T2FLAIR, contrast-enhanced T1WI, and multi-b-value DWI. Postoperative follow-up or secondary surgery pathology confirmed 46 cases of TR and 36 cases of PsP. Six diffusion models were fitted based on multi-b-value DWI sequences, including monoexponential DWI (Mono_DWI), intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI), stretched-exponential model (SEM), fractional-order calculus (FROC), and continuous-time random-walk (CTRW) model. ROIs were manually outlined to calculate the average values of each parameter. Differences between the two groups were compared using T-tests or Mann-Whitney U tests. The diagnostic performance of individual parameters was analyzed using ROC curve analysis, and the diagnostic performance of each model was compared using multivariate logistic regression.
Results: Among the 14 parameter maps, significant differences were found in all models (P<0.0036) except for IVIM_D*, IVIM_f. ROC curve analysis showed that CTRW_D demonstrated the highest AUC of 0.8484 (0.7549-0.9240). Further analysis of the diffusion models showed that CTRW performed the best among all models, with an AUC of 0.8635 (0.7816-0.9454), slightly higher than the FROC model, which had an AUC of 0.8629 (0.7839-0.9420).
Conclusion: The various diffusion models derived from multi-b-value DWI sequences can effectively distinguish between postoperative recurrence and pseudoprogression in gliomas. Among these models, the CTRW and FROC models are the two optimal models, demonstrating comparable diagnostic performance.
Keywords: Diffusion MRI; Glioma; Postoperative tumor recurrence; Pseudoprogression.
Copyright © 2025 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest During the creation of this work, no commercial, financial, or other interests have influenced the research process or the results, which could lead to any potential conflicts of interest.
Similar articles
-
Predicting IDH and 1p/19q molecular status of gliomas with multi-b values DWI.Front Oncol. 2025 Jul 30;15:1551023. doi: 10.3389/fonc.2025.1551023. eCollection 2025. Front Oncol. 2025. PMID: 40809035 Free PMC article.
-
Continuous-time random walk and fractional order calculus models histogram analysis of glioma biomarkers, including IDH1, ATRX, MGMT, and TERT, on differentiation.Quant Imaging Med Surg. 2025 Jul 1;15(7):6118-6136. doi: 10.21037/qims-2024-2725. Epub 2025 Jun 30. Quant Imaging Med Surg. 2025. PMID: 40727335 Free PMC article.
-
Characterizing Breast Tumor Heterogeneity Through IVIM-DWI Parameters and Signal Decay Analysis.Diagnostics (Basel). 2025 Jun 12;15(12):1499. doi: 10.3390/diagnostics15121499. Diagnostics (Basel). 2025. PMID: 40564820 Free PMC article.
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450. Health Technol Assess. 2007. PMID: 17999840
LinkOut - more resources
Full Text Sources
Miscellaneous